Skip to content
healthcare.dev

Typhim Vi

NDC 49281-790, SALMONELLA TYPHI TY2 VI POLYSACCHARIDE ANTIGEN, injection, solution, from Sanofi Vaccines US Inc..

Product NDC
49281-790
Status
Listed
Labeler
Sanofi Vaccines US Inc.
Dosage form
INJECTION, SOLUTION
Route
INTRAMUSCULAR
Product type
VACCINE
Marketing category
BLA
Application
BLA103936
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/49281-790 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • SALMONELLA TYPHI TY2 VI POLYSACCHARIDE ANTIGEN25 ug/.5mL

Pharmacologic classes

Actively Acquired Immunity [PE]; Inactivated Salmonella Typhi Vaccine [EPC]; Polysaccharides, Bacterial [CS]; Vaccines, Inactivated [CS]; Vaccines, Typhoid [CS]

Package NDCNDC-11Package
49281-790-20492810790201 VIAL, MULTI-DOSE in 1 PACKAGE (49281-790-20) / 10 mL in 1 VIAL, MULTI-DOSE (49281-790-38)
49281-790-51492810790511 SYRINGE in 1 PACKAGE (49281-790-51) / .5 mL in 1 SYRINGE (49281-790-88)

Linked data

RxNorm, label and prices

Use it

Look up 49281-790 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/49281-790 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 49281-790. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.